Condition
Distal Cholangiocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Distal Cholangiocarcinoma clinical trials that are recruiting, at sites in 3 countries (most in Netherlands (1), China (1), Egypt (1)). By phase: Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Distal Cholangiocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Modified single-incision plus one-port laparoscopic pancreatoduodenectomy vs conventional five-port laparoscopic pancreatoduodenectomy for non-pancreatic periampullary cancers | — | Chongqing, Chongqing Municipality and 3 other locations | Recruiting | Aug 4, 2026 |
| Laparoscopic versus open pancreaticoduodenectomy outcomes | — | Minya, Minya Governorate | Recruiting | Jan 9, 2026 |
| Neoadjuvant gemcitabine and cisplatin with perioperative pembrolizumab vs upfront surgery for cancers of the bile ducts | Phase 2/3 | Amsterdam | Recruiting | Apr 11, 2025 |
All recruiting trials (3)
-
Modified single-incision plus one-port laparoscopic pancreatoduodenectomy vs conventional five-port laparoscopic pancreatoduodenectomy for non-pancreatic periampullary cancers
This trial tests whether a less invasive single-incision plus one-port approach can match the safety and effectiveness of the standard five-port surgery in adults with non-pancreatic periampullary cancers requiring pancreaticoduodenectomy.
-
Laparoscopic versus open pancreaticoduodenectomy outcomes
This trial will test whether laparoscopic (keyhole) pancreaticoduodenectomy leads to fewer complications and faster recovery than open pancreaticoduodenectomy in adults with resectable pancreatic or periampullary tumors.
-
Neoadjuvant gemcitabine and cisplatin with perioperative pembrolizumab vs upfront surgery for cancers of the bile ducts
This trial tests whether giving chemotherapy with pembrolizumab before surgery helps people with resectable or borderline resectable extrahepatic cholangiocarcinoma see if they have better outcomes than going straight to surgery.
Related topics
Quick answers
How many Distal Cholangiocarcinoma clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Netherlands (1 trial), China (1 trial), Egypt (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.